29 reports

  • Vendor landscape
  • Key vendor analysis

MARKET OVERVIEW Ohr Pharmaceutical s F.

  • Pharmaceutical
  • Therapy
  • Bayer AG
  • Hoffmann-La Roche Inc.
  • Novartis AG
  • KEY TAKEAWAY: COMPANIES WITH A STRONG INTEGRATION OF R&D AND MARKETING ARE LIKELY TO SUCCEED
  • Pipeline analysis
  • Lung Cancer
  • Pharmaceutical
  • AstraZeneca PLC
  • Celgene Corporation
  • Hoffmann-La Roche Inc.
  • Key vendor analysis
  • F. Hoffmann-La Roche

Develops, manufactures, and markets pharmaceuticals worldwide.

  • Pharmaceutical
  • Vaccine
  • Amgen Inc.
  • Hoffmann-La Roche Inc.
  • Novo Nordisk Group
  • Vendor landscape
  • Pipeline Portfolio

As of December 2014, the Diagnostics ##% Pharmaceuticals ##% Diagnostics Pharmaceuticals company employed ##, ## people worldwide.

  • Asthma
  • Pharmaceutical
  • Respiratory Treatment
  • Market Size
  • Hoffmann-La Roche Inc.
  • Global hepatitis therapeutics market
  • Vendor landscape

ICN Pharmaceuticals, Ribapharm, and F.

  • Digestive System Disorder
  • Hepatitis
  • Pharmaceutical
  • Gilead Sciences, Inc.
  • Hoffmann-La Roche Inc.
  • Vendor landscape
  • Market trends

Epoetin Alfa BS injection by JCR Pharmaceuticals and Kissei Pharmaceutical is a biosimilar version of Epoetin Alfa.

  • Pharmaceutical
  • Therapy
  • Amgen Inc.
  • Hoffmann-La Roche Inc.
  • Merck & Co., Inc.

HOFFMANN-LA ROCHE E## Peginterferon alfa-##a TRO## EA PHARMA |EISAI INC.

  • Digestive System Disorder
  • Pharmaceutical
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • MARKET SHARE

Non-drug therapies are substitutes for many pharmaceuticals.

  • Pharmaceutical
  • F. Hoffmann-La Roche Ltd.
  • Hoffmann-La Roche Inc.
  • Novartis AG
  • Pfizer Inc.
  • Vendor landscape

April 2015: Valeant Pharmaceuticals completes the acquisition of Salix Pharmaceuticals.

  • Digestive System Disorder
  • Pharmaceutical
  • Therapy
  • Gilead Sciences, Inc.
  • Hoffmann-La Roche Inc.
  • Vendor landscape
  • Market landscape

This has helped the company strengthen its position in the pharmaceuticals sector.

  • Hormones
  • Pharmaceutical
  • Hoffmann-La Roche Inc.
  • Novartis AG
  • Novo Nordisk Group
  • Vendor landscape
  • TOP-VENDOR OFFERINGS

Engages in supplying pharmaceutical products worldwide.

  • Pharmaceutical
  • Respiratory Treatment
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • Vendor landscape
  • Scope of the report

AstraZeneca, Arena Pharmaceuticals, F.

  • Obesity
  • Pharmaceutical
  • United States
  • Market Size
  • Hoffmann-La Roche Inc.
  • New Product launches
  • 9. COMPANY PROFILES

AstraZeneca Pharma India Limited (AZPIL) signed a distribution agreement with Sun Pharma.

  • Diabetes
  • Diabetes Care
  • Insulin
  • Pharmaceutical
  • Hoffmann-La Roche Inc.
  • Key vendor analysis
  • Opportunities

ADVAXIS BIONOR PHARMA DENDREON ISA PHARMACEUTICALS OTSUKA PHARMACEUTICAL PROFECTUS VIROMETIX Company ZERIA PHARMACEUTICAL Description It develops globally innovative products for oncology, anemia, dyspepsia, and ulcerative colitis.

  • Pharmaceutical
  • Vaccine
  • World
  • Market Size
  • Hoffmann-La Roche Inc.

Roche' s Pharmaceuticals division consists of two business segments, Roche Pharmaceuticals, and Chugai.

  • Pharmaceutical
  • Therapy
  • Europe
  • Market Size
  • Hoffmann-La Roche Inc.
  • SCOPE OF THE REPORT

April 2015: Innate Pharma enters into a collaboration agreement with Sanofi to apply Innate Pharma' s site-specific conjugation technology to develop new ADCs.

  • Pharmaceutical
  • Therapy
  • Hoffmann-La Roche Inc.
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • Vendor landscape
  • GILEAD SCIENCES

Celtic Pharma acquired IDEA Pharma in February 2006.

  • Anti-Infective
  • Infectious Disease
  • Pharmaceutical
  • Gilead Sciences, Inc.
  • Hoffmann-La Roche Inc.
  • Vendor landscape

THE COMPANY FOCUSES ON MANUFACTURING PHARMACEUTICALS FOR HUMAN AND ANIMAL HEALTH.

  • Pharmaceutical
  • United States
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • F. HOFFMANN-LA ROCHE
  • FIVE FORCES ANALYSIS

TRIUMEQ Key products TRIVICAY JANSSEN PHARMACEUTICALS Business overview Janssen Pharmaceuticals is a subsidiary of Johnson and Johnson.

  • Pharmaceutical
  • World
  • Forecast
  • Market Size
  • Hoffmann-La Roche Inc.
  • MARKET SHARE ANALYSIS 2015
  • Vendor landscape

Develops pharmaceutical products.

  • Pharmaceutical
  • Vaccine
  • United States
  • World
  • Hoffmann-La Roche Inc.
  • 20.1 COMPETITIVE SCENARIO
  • 21. Key Vendor Analysis

It is the second largest pharmaceutical group in Europe, and the third largest pharmaceutical group in the world.

  • Breast Cancer
  • Pharmaceutical
  • Therapy
  • Celgene Corporation
  • Hoffmann-La Roche Inc.
  • Key takeaway: Companies with a strong integration of marketing and R&D is likely to succeed
  • F. HOFFMANN-LA ROCHE

DEVELOPS AND MANUFACTURES PHARMACEUTICALS.

  • Autoimmune Disease
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Hoffmann-La Roche Inc.
  • Key takeaway: Companies with a strong integration of marketing and R&D are likely to
  • KEY VENDOR ANALYSIS

Takeda Pharmaceuticals researches, develops, manufactures, sells, imports, and exports pharmaceutical drugs.

  • Cancer
  • Pharmaceutical
  • Therapy
  • Amgen Inc.
  • Hoffmann-La Roche Inc.
  • MARKET SHARE ANALYSIS 2015
  • Vendor landscape

Develops pharmaceutical products.

  • Pharmaceutical
  • Vaccine
  • United States
  • World
  • Hoffmann-La Roche Inc.
  • ELI LILLY
  • MARKET ANALYSIS 2014

THE COMPANY DEVELOPS, MANUFACTURES, AND DISTRIBUTES PHARMACEUTICAL PRODUCTS WORLDWIDE.

  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • AstraZeneca PLC
  • Hoffmann-La Roche Inc.
  • JW PHARMA ENTERS INTO LICENSING AGREEMENT WITH CHUGAI PHARMA
  • CHUGAI PHARMA ENTERS INTO LICENSING AGREEMENT WITH SBI PHARMA
  • Healthcare
  • Hospital
  • Pharmaceutical
  • Therapy
  • Hoffmann-La Roche Inc.
  • DEAL REPORT: ROCHE HOLDING ACQUIRES ANADYS PHARMACEUTICALS
  • DEAL IN BRIEF
  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Hoffmann-La Roche Inc.
  • OVERVIEW
  • F. Hoffmann-La Roche Ltd: Locations and Subsidiaries

Roche' s Pharmaceuticals division consists of two business segments, Roche Pharmaceuticals, and Chugai.

  • Pharmaceutical
  • Therapy
  • United States
  • Company
  • Hoffmann-La Roche Inc.
  • OVERVIEW
  • F. Hoffmann-La Roche Ltd: Locations and Subsidiaries

Roche' s Pharmaceuticals division consists of two business segments, Roche Pharmaceuticals, and Chugai.

  • Pharmaceutical
  • Therapy
  • United States
  • Company
  • Hoffmann-La Roche Inc.